Silco Pharmaceuticals Management
Management criteria checks 2/4
We currently do not have sufficient information about the CEO.
Key information
Md. Haque Rukan
Chief executive officer
৳540.0k
Total compensation
| CEO salary percentage | 100.0% |
| CEO tenure | no data |
| CEO ownership | n/a |
| Management average tenure | no data |
| Board average tenure | no data |
Recent management updates
Recent updates
CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Mar 31 2024 | n/a | n/a | ৳43m |
| Dec 31 2023 | n/a | n/a | ৳48m |
| Sep 30 2023 | n/a | n/a | ৳50m |
| Jun 30 2023 | ৳540k | ৳540k | ৳69m |
| Mar 31 2023 | n/a | n/a | ৳68m |
| Dec 31 2022 | n/a | n/a | ৳82m |
| Sep 30 2022 | n/a | n/a | ৳79m |
| Jun 30 2022 | ৳540k | ৳540k | ৳84m |
| Mar 31 2022 | n/a | n/a | ৳88m |
| Dec 31 2021 | n/a | n/a | ৳87m |
| Sep 30 2021 | n/a | n/a | ৳86m |
| Jun 30 2021 | ৳540k | ৳540k | ৳85m |
| Mar 31 2021 | n/a | n/a | ৳84m |
| Dec 31 2020 | n/a | n/a | ৳76m |
| Sep 30 2020 | n/a | n/a | ৳88m |
| Jun 30 2020 | ৳540k | ৳540k | ৳83m |
| Mar 31 2020 | n/a | n/a | ৳163m |
| Dec 31 2019 | n/a | n/a | ৳167m |
| Sep 30 2019 | n/a | n/a | ৳168m |
| Jun 30 2019 | ৳540k | ৳540k | ৳162m |
| Mar 31 2019 | n/a | n/a | ৳106m |
| Dec 31 2018 | n/a | n/a | ৳105m |
| Sep 30 2018 | n/a | n/a | ৳104m |
| Jun 30 2018 | ৳540k | n/a | ৳105m |
Compensation vs Market: Md.'s total compensation ($USD4.50K) is below average for companies of similar size in the BD market ($USD20.41K).
Compensation vs Earnings: Md.'s compensation has been consistent with company performance over the past year.
CEO
Md. Haque Rukan (71 yo)
no data
Tenure
৳540,000
Compensation
Dr. Md. Badrul Haque Rukan serves as the Managing Director and Director of Silco Pharmaceuticals Ltd. Dr. Rukan is a prominent Child Specialist is Sylhet city completed his MBBS, DCH from DUB, also achieve...